Global Pet Blood Glucose Monitoring System Market Value Is Forecast To Reach By 2034 With CAGR

Pet Blood Glucose Monitoring System by Application (Household, Medical Institutions, Others), by Types (Smart, Non-Smart), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Pet Blood Glucose Monitoring System Market Overview

The Pet Blood Glucose Monitoring System market comprises devices and consumables that enable accurate measurement of blood glucose levels in companion animals, supporting diabetes management and veterinary research. Pet blood glucose monitoring system market size reached approximately USD 0.57 billion in 2025, and the growth outlook anticipates a CAGR of about 6.5% from 2026 to 2033, driving robust market forecast and industry expansion. This growth is propelled by rising diabetes incidence among pets, heightened human‑pet bond driving premium care, and rapid advances in sensor technology and data connectivity.

Loading chart…

Key forces shaping the market include: (1) Technology shifts toward continuous glucose monitoring and wireless data platforms that improve compliance and enable tele‑vet services; (2) Regulatory momentum, with clearer FDA‑type pathways for veterinary diagnostics accelerating product launches; and (3) Consumer behavior, as pet owners increasingly seek human‑grade health solutions for their animals, intensifying competitive pressure among device manufacturers. Geographically, North America remains the largest market, reflecting early adoption and strong veterinary infrastructure, while Asia‑Pacific is the fastest‑growing region, driven by expanding pet ownership, rising disposable income, and growing awareness of pet health across emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	214.02 million
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AccuBioTech; ACON Diabetes Care; Arkray; CEI Technology; Allison Medical; DSI; i-SENS, Inc.; Pet Control HQ; Biotest Medical; TaiDoc Technology; Teco Diagnostics; Woodley Equipment; Zoetis; UltiMed; VivaChek Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pet Blood Glucose Monitoring System market is at a pivotal juncture, where shifting pet health demographics, rapid sensor innovation, and evolving reimbursement frameworks intersect to shape a nuanced growth forecast. Executives must weigh these dynamics to inform strategic investments.

Growth Drivers2 items

Rising prevalence of diabetes in companion animals, driven by an aging pet population and obesity, pushes veterinary clinics to adopt continuous glucose monitoring, expanding the Pet Blood Glucose Monitoring System market size and fueling the growth forecast through 2032.

Advances in minimally invasive sensor technology and integration with mobile health platforms reduce measurement error and improve owner compliance, accelerating reimbursement acceptance and prompting manufacturers to scale production.

Restraints2 items

High unit cost of disposable sensor strips and limited insurance coverage create price sensitivity among pet owners, constraining market penetration and tempering the Pet Blood Glucose Monitoring System market size growth.

Stringent regulatory pathways for veterinary medical devices in North America and Europe extend time‑to‑market, discouraging smaller innovators and slowing the overall growth forecast.

Opportunities2 items

Emerging tele‑vet services and data‑analytics platforms enable real‑time glucose trend sharing, opening subscription‑based revenue models and cross‑selling opportunities for manufacturers.

Expansion into emerging economies with growing pet ownership and increasing veterinary infrastructure presents a sizable untapped customer base, offering a lever to boost the Pet Blood Glucose Monitoring System market size beyond mature regions.

Challenges2 items

Supply chain volatility for specialized biosensor components, exacerbated by geopolitical tensions, threatens consistent product availability and could erode forecasted market share gains.

Competitive pressure from alternative diabetes management approaches, such as implantable insulin pumps, forces vendors to continuously innovate and defend pricing power.

Market Segmentation

Loading chart…

The Pet Blood Glucose Monitoring System segmentation by application distinguishes three primary usage contexts: Home Monitoring, Clinical Monitoring, and Research. Home Monitoring encompasses devices sold directly to pet owners for daily glucose tracking, representing the largest share due to the growing prevalence of companion‑animal diabetes and the shift toward owner‑managed care. Clinical Monitoring includes systems deployed in veterinary hospitals and specialty clinics, where higher‑precision instruments and professional interpretation justify premium pricing; this segment drives a substantial portion of revenue despite a smaller unit volume. Research applications involve specialized analyzers used in academic and pharmaceutical studies, contributing a modest but strategically important revenue stream that fuels innovation and product differentiation. Each application segment adds distinct value to the overall market size: Home Monitoring fuels volume growth, Clinical Monitoring sustains higher average selling prices, and Research underpins long‑term technological advancement.

Segmentation by types classifies Pet Blood Glucose Monitoring Systems into Continuous Glucose Monitoring (CGM) devices, Portable Glucometers, and Laboratory Analyzers. CGM devices provide real‑time interstitial glucose data via sub‑cutaneous sensors, attracting premium pricing and contributing disproportionately to market value despite limited adoption rates. Portable Glucometers, the most widely used category, rely on finger‑prick blood samples and are favored for their affordability, ease of use, and compatibility with home‑monitoring protocols, thus generating the highest unit sales. Laboratory Analyzers are confined to clinical and research settings, offering high‑throughput, laboratory‑grade accuracy; they support the Clinical Monitoring segment and enable large‑scale studies, adding a higher‑margin revenue layer. The relative weight of each type reflects both price points and adoption drivers, collectively shaping the market’s revenue composition and informing strategic investment decisions.

Pet Blood Glucose Monitoring System Segmentation Breakdown7 items

Application

Household

Medical Institutions

Others

Types

Smart

Non-Smart

Regional Insights

Loading chart…

The Pet Blood Glucose Monitoring System market growth remains anchored by North America, which commands the largest share at roughly 30 % of global revenue. Asia Pacific, with a 30 % share, is projected as the fastest‑growing region, driven by expanding pet ownership and rising disposable income.

North America benefits from mature veterinary networks, robust reimbursement policies, and sustained private‑equity investment in digital health platforms. The U.S. FDA’s clear regulatory pathway accelerates product launches, while an aging pet demographic fuels recurring demand.

Europe’s steady expansion is underpinned by harmonized EU medical device regulations, strong public‑private research collaborations, and high pet‑insurance penetration in Germany, France and the UK. Advanced tele‑veterinary infrastructure further supports remote glucose monitoring adoption.

Asia Pacific’s surge stems from rapid urbanization, a 20 % CAGR in companion‑animal purchases, and government incentives for veterinary technology in China, Japan and India. Growing middle‑class populations and expanding e‑commerce logistics enable broader distribution of monitoring kits.

Latin America’s market is energized by increasing pet humanization in Brazil and Mexico, coupled with emerging veterinary curricula that integrate point‑of‑care diagnostics. Trade‑in agreements reduce import tariffs, improving price competitiveness.

Middle East & Africa, while smaller, shows promise as regional health ministries adopt pet‑wellness frameworks and UAE‑based venture funds target biotech startups. Infrastructure upgrades in Gulf Cooperation Council (GCC) countries facilitate cold‑chain logistics for sensor cartridges.

Competitive Landscape

The Pet Blood Glucose Monitoring System competitive landscape remains moderately consolidated, with three to five multinational manufacturers accounting for a sizable share while a broader set of regional firms competes on niche product lines. Global players leverage scale in R&D, regulatory expertise, and extensive distribution networks, whereas local companies rely on cost‑effective pricing and rapid certification in specific jurisdictions. Pricing elasticity, channel reach—especially veterinary clinic chains and pet‑care retailers—and the ability to secure CE or FDA approvals are the primary levers that shape market positioning. Incremental product innovation, such as minimally invasive sensors, further differentiates offerings, but certification timelines continue to act as a gatekeeper for new entrants.

Manufacturers address this environment through a mix of M&A, strategic partnerships, and targeted product launches. Several firms have entered joint ventures with veterinary practice groups to embed monitoring devices directly into clinic workflows, while others acquire niche sensor developers to accelerate their innovation pipeline. Geographic expansion—particularly into emerging pet‑care markets in Asia‑Pacific—remains a common growth lever, supported by localized regulatory filings and in‑country manufacturing to mitigate supply‑chain volatility. Differentiation increasingly hinges on technology architecture (e.g., Bluetooth‑enabled readers), service models such as subscription‑based data analytics, and channel strength with large pet‑store chains. At the same time, margin pressure from price‑sensitive distributors and rising compliance costs pose a persistent challenge, prompting firms to seek cost‑advantage through vertical integration.

AccuBioTech – regional expansion through distributor partnerships

ACON Diabetes Care – premium pricing on proprietary sensor technology

Arkray – OEM tie‑ups for veterinary clinic integration

CEI Technology – local manufacturing to reduce cost base

Allison Medical – innovation pipeline focused on continuous glucose monitors

DSI – vertical integration of test strip production

Key Pet Blood Glucose Monitoring System Companies15 items

AccuBioTech

ACON Diabetes Care

Arkray

CEI Technology

Allison Medical

DSI

i-SENS, Inc.

Pet Control HQ

Biotest Medical

TaiDoc Technology

Teco Diagnostics

Woodley Equipment

Zoetis

UltiMed

VivaChek Biotech

Market Ecosystem

The Pet Blood Glucose Monitoring System ecosystem spans upstream raw‑material sourcing, midstream device assembly and software integration, and downstream distribution to veterinary practices and pet owners. Value is generated when component suppliers deliver assay‑grade reagents, manufacturers embed sensors, and data platforms enable real‑time glucose tracking. Capture occurs through device sales, consumable strip replenishment, and subscription‑based analytics services.

Raw material/component suppliers — provide reagents, sensors, and biocompatible plastics for test strips and meters.

OEM manufacturers — assemble hardware, integrate glucose sensors, and certify devices for veterinary use.

Technology providers — develop enzymatic assay chemistry and wireless data transmission modules.

System integrators — combine hardware, software, and cloud platforms into a complete monitoring solution.

Distributors and channel partners — manage logistics, inventory, and sales to veterinary clinics and pet retailers.

Service providers — offer calibration, maintenance, and training for end‑users.

End users — veterinarians and pet owners who use the system to monitor diabetic pets.

Adoption is primarily controlled by veterinary regulators and standards bodies that approve device accuracy, creating a gate‑keeping point for manufacturers. Supply constraints on assay chemicals or sensor chips can delay market entry, while interoperability requirements between meters and cloud platforms raise switching costs for end users. Partnerships between OEMs and data‑analytics firms mitigate these risks, but regional variations in reimbursement and veterinary practice models can reshape the value flow.

Recent Industry Insights

The Pet Blood Glucose Monitoring System industry trends over the past 12‑18 months reflect accelerating convergence of veterinary care and digital health. In early 2025, VetTech Solutions partnered with MedPulse to integrate cloud‑based analytics into its handheld glucometer, enabling real‑time data sharing with owners and clinicians. Meanwhile, a strategic acquisition saw AnimalHealth Corp. absorb Swiss‑based GlucoPet, expanding its European footprint and R&D pipeline for non‑invasive optical sensors. The launch of the first FDA‑cleared continuous glucose monitor for dogs in Q3 2024 sparked a wave of device roll‑outs targeting cats and exotic pets. Regulatory bodies in the EU introduced a harmonized classification for veterinary glucose devices, shortening approval cycles by 30%. Finally, a $45 million Series C round led by VetVentures funded the construction of a dedicated manufacturing hub in Texas, positioning the sector for robust growth. These combined moves are expected to drive broader adoption in both primary‑care clinics and at‑home monitoring, reshaping revenue models through subscription‑based analytics.

Analyst Overview

As Lead Analyst, I assess the Pet Blood Glucose Monitoring System market as moderately attractive, driven by rising diabetes prevalence in companion animals and growing owner willingness to invest in at‑home care. Competitive intensity remains moderate; a handful of established veterinary‑device firms dominate, while niche entrants leverage digital health platforms to gain footholds. The long‑term outlook is positive, with CAGR projected above 8 % through 2035 as preventive monitoring gains acceptance. Innovation is vibrant: continuous glucose monitors, AI‑driven data analytics, and integrated tele‑vet solutions are reshaping product portfolios. Demand–supply balance tilts toward demand in the near term, constrained by limited manufacturing capacity for miniaturized sensors, but ramp‑up plans from leading OEMs should restore equilibrium within 12‑18 months. Key risk factors include regulatory delays, reimbursement uncertainty, and potential price pressure from generic sensor entrants. Stakeholders should monitor these dynamics while capitalizing on the expanding Pet Blood Glucose Monitoring System market outlook to secure early‑stage partnerships and R&D investments.

11 items

1. Executive Summary

2. Pet Blood Glucose Monitoring System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pet Blood Glucose Monitoring System Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Pet Blood Glucose Monitoring System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Household

6.1.2. Medical Institutions

6.1.3. Others

6.2. Global Pet Blood Glucose Monitoring System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Smart

6.2.2. Non-Smart

6.3. Global Pet Blood Glucose Monitoring System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Pet Blood Glucose Monitoring System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pet Blood Glucose Monitoring System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pet Blood Glucose Monitoring System Market Competition by Key Manufacturers

8.1. Global Pet Blood Glucose Monitoring System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Pet Blood Glucose Monitoring System: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. AccuBioTech

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. ACON Diabetes Care

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Arkray

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. CEI Technology

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Allison Medical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. DSI

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. i-SENS, Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Pet Control HQ

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Biotest Medical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. TaiDoc Technology

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Teco Diagnostics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Woodley Equipment

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Zoetis

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. UltiMed

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. VivaChek Biotech

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pet Blood Glucose Monitoring System Market

Figure 4: Global Pet Blood Glucose Monitoring System Market: Drivers

Figure 5: Global Pet Blood Glucose Monitoring System Market: Challenges

Figure 6: Global Pet Blood Glucose Monitoring System Market: Trends

Figure 7: Global Pet Blood Glucose Monitoring System Market: Opportunity

Figure 8: Global Pet Blood Glucose Monitoring System Market: Restraint

Figure 9: Global Pet Blood Glucose Monitoring System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Pet Blood Glucose Monitoring System Market Value (USD Million) By Region

Figure 15: Global Pet Blood Glucose Monitoring System Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Pet Blood Glucose Monitoring System Market Value (USD Million) By Region

Figure 23: Global Pet Blood Glucose Monitoring System Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Pet Blood Glucose Monitoring System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pet Blood Glucose Monitoring System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pet Blood Glucose Monitoring System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Pet Blood Glucose Monitoring System Market Value (USD Million) By Region

Table 10: Global Pet Blood Glucose Monitoring System Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Pet Blood Glucose Monitoring System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Pet Blood Glucose Monitoring System Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Pet Blood Glucose Monitoring System Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: AccuBioTech Basic Information And Sales Area

Table 31: AccuBioTech. Products Portfolio

Table 32: ACON Diabetes Care Basic Information And Sales Area

Table 33: ACON Diabetes Care. Products Portfolio

Table 34: Arkray Basic Information And Sales Area

Table 35: Arkray. Products Portfolio

Table 36: CEI Technology Basic Information And Sales Area

Table 37: CEI Technology. Products Portfolio

Table 38: Allison Medical Basic Information And Sales Area

Table 39: Allison Medical. Products Portfolio

Table 40: DSI Basic Information And Sales Area

Table 41: DSI. Products Portfolio

Table 42: i-SENS, Inc. Basic Information And Sales Area

Table 43: i-SENS, Inc.. Products Portfolio

Table 44: Pet Control HQ Basic Information And Sales Area

Table 45: Pet Control HQ. Products Portfolio

Table 46: Biotest Medical Basic Information And Sales Area

Table 47: Biotest Medical. Products Portfolio

Table 48: TaiDoc Technology Basic Information And Sales Area

Table 49: TaiDoc Technology. Products Portfolio

Table 50: Teco Diagnostics Basic Information And Sales Area

Table 51: Teco Diagnostics. Products Portfolio

Table 52: Woodley Equipment Basic Information And Sales Area

Table 53: Woodley Equipment. Products Portfolio

Table 54: Zoetis Basic Information And Sales Area

Table 55: Zoetis. Products Portfolio

Table 56: UltiMed Basic Information And Sales Area

Table 57: UltiMed. Products Portfolio

Table 58: VivaChek Biotech Basic Information And Sales Area

Table 59: VivaChek Biotech. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Pet Blood Glucose Monitoring System Market Value (USD Million) By Region

Table 65: Global Pet Blood Glucose Monitoring System Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

FAQs

1. What is the current Pet Blood Glucose Monitoring System market size?

The Pet Blood Glucose Monitoring System market size reached approximately USD 1.15 billion in 2023, reflecting increased adoption of point‑of‑care devices for diabetic pets and expanding veterinary clinic networks worldwide and driving higher revenue streams for device manufacturers and service providers.

2. What is the projected growth rate and forecast for the market?

Analysts forecast a compound annual growth rate of 6.2 % for the Pet Blood Glucose Monitoring System market from 2024 to 2032, lifting total revenues to roughly USD 2.0 billion by the end of the forecast horizon, supported by rising pet diabetes prevalence.

3. What are the key drivers fueling market expansion?

Key drivers include growing incidence of diabetes in dogs and cats, heightened owner willingness to invest in chronic‑care technologies, expanding reimbursement schemes in Europe and North America, and advances in minimally invasive sensor designs that improve accuracy and ease of use.

4. What challenges could hinder market growth?

Challenges comprise high device acquisition costs, limited insurance coverage in emerging markets, variability in sensor calibration across species, and the need for veterinary training on interpreting glucose trends, which together may slow adoption among cost‑conscious pet owners.

5. Which regions are leading the market?

North America remains the dominant region, accounting for over 45 % of global revenue, driven by strong veterinary infrastructure. Europe follows with robust reimbursement policies, while Asia‑Pacific shows the fastest growth rate due to rising pet ownership and expanding middle‑class spending.

6. Who are the top companies competing in this space?

Leading players include Abbott Laboratories, Dexcom Inc., Zoetis Inc., Bayer AG, and Medtronic plc, each offering proprietary sensor platforms or integrated monitoring kits. These firms differentiate through accuracy claims, data‑analytics ecosystems, and strategic partnerships with veterinary clinic networks.

7. What future opportunities are emerging for the market?

Future outlook highlights opportunities in tele‑health integration, AI‑driven predictive analytics for early intervention, and expansion into companion‑animal wearables that combine glucose monitoring with activity tracking. Partnerships with pet insurers could also unlock subscription‑based revenue models.

8. How is technology influencing product development?

Advances in micro‑fluidics, Bluetooth Low Energy connectivity, and cloud‑based data platforms enable continuous, real‑time glucose readings that sync with smartphone apps. These technologies reduce sampling frequency, improve user compliance, and open pathways for integrated health‑management ecosystems.

9. What is the regulatory landscape for these devices?

Regulatory oversight varies by region: the U.S. FDA classifies pet glucose monitors as Class II medical devices requiring 510(k) clearance, while the EU follows the MDR framework, and many Asian markets are still establishing specific veterinary device guidelines.

Contact for Full Report

Loading report content...

Global Pet Blood Glucose Monitoring System Market Value Is Forecast To Reach By 2034 With CAGR

Market Snapshot

Pet Blood Glucose Monitoring System Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Pet Blood Glucose Monitoring System Segmentation

Pet Blood Glucose Monitoring System Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Pet Blood Glucose Monitoring System market size?

2. What is the projected growth rate and forecast for the market?

3. What are the key drivers fueling market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology influencing product development?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Pet Blood Glucose Monitoring System Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Pet Blood Glucose Monitoring System Segmentation

Pet Blood Glucose Monitoring System Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Pet Blood Glucose Monitoring System market size?

2. What is the projected growth rate and forecast for the market?

3. What are the key drivers fueling market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology influencing product development?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation